ELISA: 1:20-1:200, IF: 1:10-1:50, IHC: 1:10-1:50, WB: 1:10-1:50 Optimal conditions should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
Lot specific
Buffer
Liquid in 0.01 M phosphate buffered saline, pH 7.2 with 0.1 % sodium azide
Vorsichtsmaßnahmen
This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
Handhabung
Avoid repeated freeze/thaw cycles. Dilute only prior to immediate use.
Lagerung
-20 °C
Informationen zur Lagerung
Aliquot and store at -20 °C.
Al-Atrache, Lopez, Hingley, Appelt: "Astrocytes infected with Chlamydia pneumoniae demonstrate altered expression and activity of secretases involved in the generation of β-amyloid found in Alzheimer disease." in: BMC neuroscience, Vol. 20, Issue 1, pp. 6, (2019) (PubMed).
Freitas, Almeida, Freitas Queiroz, Zaninotto, Fuzii, Ribeiro-Silva, Vallinoto, Ishak, Quaresma, Ishak: "In situ detection of Chlamydia pneumoniae, C. trachomatis, and cytokines among cardiovascular diseased patients from the Amazon region of Brazil." in: Infection and drug resistance, Vol. 10, pp. 109-114, (2017) (PubMed).
Chlamydophila pneumoniae is a species of Chlamydophila bacteria that infects humans and is a major cause of pneumonia. C. pneumoniae has a complex life cycle and must infect another cell in order to reproduce, thus it is classified as an obligate intracellular pathogen. The full genome sequence for C. pneumoniae was published in 1999. Synonyms: Monoclonal Chlamydia pneumoniae antibody, Anti-Chlamydia pneumoniae antibody.